Varenicline inhibited SARS-CoV-2 in monkeys, with no changes in the rapidity of breathing, respiratory trouble, or fecal consistency. There were only small changes in body weight and temperature.

The paper 'Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial' was published in PLOS ONE this week. ### ...

Oyster Point Pharma takes seriously the quality of products in development and patient safety. To date, Oyster Point Pharma has tested samples of varenicline tartrate API intermediate, multiple ...

The labeling for Chantix (varenicline tartrate, from Pfizer) has been updated with a warning to observe patients for serious neuropsychiatric symptoms, including changes in behavior, agitation ...

New Drug To Curb Smoking Shows Positive Results Date: April 3, 2009 Source: Wiley - Blackwell Summary: Research has shown that varenicline tartrate - a novel new drug specifically developed for ...

FARMINGTON, Conn. -- Many patients taking Chantix (varenicline tartrate) to help kick the smoking habit could be spared the side effect of nausea if introduced to the drug gradually, researchers here ...

SAN FRANCISCO (MarketWatch) -- Pfizer Inc. said Wednesday that the Food and Drug Administration has granted a 6-month priority review for the new drug application for its smoking cessation ...

Although physicians often consider increasing a medication dose if there is no response to the standard dose in a patient, this strategy may not be effective with varenicline for smoking cessation ...

Varenicline tartrate (Chantix/Champix; Pfizer Inc; New York, New York), a high-affinity α 4 β 2 nicotinic acetylcholine receptor partial agonist, is hypothesized to reduce craving and withdrawal ...

Varenicline tartrate (Chantix, Pfizer, New York, NY, USA) was developed as a partial agonist at the α4β2 nicotinic acetylcholine receptor (nAChR) 1, 2 and was approved by the Food and Drug ...